Metastatic disease
Astragalus Polysaccharide (PG2) Ameliorates Cancer Symptom Clusters, as Well as Improves Quality of Life in Patients with Metastatic Disease, Through Modulation of the Inflammatory Cascade
... symptom clusters, as well as improves quality of life in patients with metastatic disease, through. down-modulation of the inflammatory cascade[r] ...
19
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients
... of disease burden miRNA markers changes during treatment of metastatic NB ...monitor disease burden during treat- ment of NB patients diagnosed with metastatic ...for metastatic ...
14
Cutaneous Metastatic Disease: Case Series in a Tropical Setting
... cutaneous metastatic disease as demonstrated in the patient with metastatic olfactory neuroblastoma while under treatment with chemotherapy and radiotherapy represents failure of current treat- ment ...
7
Metastatic disease to the breast: the Washington University experience
... Metastatic disease to the breast occurs rarely, but may become an increasingly frequent diagnosis as patients continue to live longer with malignant ...malignancies. Metastatic neo- plasms to the ...
8
Metastatic Disease: Interactions Between Tumor Cells and Host Environment During Cancer Cell Spread
... of metastatic disease, treatment of one facet of patient health can have an impact on overall patient outcome, potentially beyond the expected mechanism of the ...
160
Voltage-gated sodium channels and metastatic disease
... A growing body of evidence suggests that VGSCs play an important pathological role during cancer progression towards metastasis. However, the role of individual α and β subunits appears to be complex. Nonetheless, a ...
33
Metastatic Disease of the Proximal Femur
... Metastatic Disease of the Proximal Femur CASE REPORT Metastatic Disease of the Proximal Femur WI Faisham, M Med{Ortho)*, W Zulmi, M S{Ortho)*, B M Biswal, MBBS** 'Department of Orthopaedic, "Departmen[.] ...
5
Metastatic disease to the pancreas: an imaging challenge
... In patients with pancreatic metastases from renal cell cancer (RCC) who have only limited disease, complete resection of all lesions can be successfully performed with a low rate of complications [38]. It seems ...
8
Safety and efficacy of denosumab in the treatment of pulmonary metastatic giant cell tumor of bone
... this metastatic disease and the unanswered questions regarding optimal use of denosumab, referral and follow-up of complicated cases of GCT requir- ing denosumab should be within expert bone cancer ...
6
Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform
... advanced disease, all patients underwent surgery with curative intent, including 16 patients with resectable metastatic disease recruited at Stanford University ...of metastatic ...
13
Brain metastases in newly diagnosed colorectal cancer: a population-based study
... with metastatic cancer, T3–T4 stage patients vs Tis, T0, T1, and T2 (OR = ...and metastatic disease to extracranial sites (bone vs none: OR = ...
10
Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma
... non-invasive technique (urine, blood), or ii) by a simple and sensitive method easily transposable to clinical practices. The presence of high amounts of mRNA in tumors of patients that relapsed toward a M1 phenotype ...
12
Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib.
... status, disease-free interval, or previous therapies in the adjuvant ...HR+ disease is clinically and biologically heterogeneous and thus there is an urgent need to identify robust prognostic and/or ...
28
Zoledronic acid in the management of metastatic bone disease
... of disease, such as biochemical relapse without metastatic disease, and is also continued in men who develop hormone-refractory ...of disease and remaining on it ...with metastatic ...
8
Haemostatic alterations in a group of canine cancer patients are associated with cancer type and disease progression
... advanced disease including decreased and increased fibrinogen level, thrombocyto- penia, prolongation of activated partial thromboplastin time (aPTT) and increased ...of metastatic disease could be ...
8
Outcome after hepatic resection for isolated non-colorectal, non-neuroendocrine liver metastases in 100 patients – the role of the embryologic origin of the primary tumor
... Hepatectomy for isolated NCNNE LM in well-selected patients is a feasible approach and results in a 5-year es- timated survival after LR of 57% (including a 10-year and 15-year survival rate: 34% and 25%, respectively). ...
9
Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives
... from metastatic deposits is not routine ...the metastatic setting are based on the features of the primary ...most metastatic sites are now accessible by minimally invasive methods, including ...of ...
8
Applying Advanced Imaging Techniques to a Murine Model of Orthotopic Osteosarcoma
... and metastatic osteosar- coma ...of disease (13, ...demonstrated disease progression in the orthotopic murine model and was unable to identify metastatic ...
11
Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma.
... and metastatic potential, is the progression of malignancy in microscopic locally residual ...the metastatic potential of microscopic locally residual ...
7
Risk factors for the development of brain metastases in patients with HER2-positive breast cancer
... of metastatic disease diagnosis, the factors included in the multivariate analyses were: age (at metastatic BC (MBC) diagnosis), menopausal status (at MBC diagnosis), primary histology, tumour grade, ...
9